[Comment] Dravet syndrome: modifying disease across the lifespan

Author profile image Aggregator
0 comments
Dravet syndrome is a severe, rare form of genetic epilepsy that serves as a model disease for understanding monogenic (single gene) developmental and epileptic encephalopathies. Affected individuals carry pathogenic variants in the sodium voltage-gated channel ฮฑ subunit 1 gene, SCN1A, causing a channelopathy that presents with difficult-to-treat seizures and multiple morbidities, including intellectual disability.1 The emergence of genetic disease-modifying therapies is expanding treatment goals in Dravet syndrome from how many seizures can be prevented to which functions can be preserved or restored.

Source: The Lancet Neurology - Current Issue Published 30 Nov 2026 Imported 19 Nov 2026 Relevancy: Not reviewed

Read the article